ADVANCED BIOMATRIX, INC. – Trademark Portfolio

Entity Type: 03

ADVANCED BIOMATRIX, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include HYSTEM, GELIN-S, GLYCOSIL, HEPRASIL, and EXTRALINK. The owner is based in CARLSBAD, CA.

5930 SEA LION PLACE

STE 100

CARLSBAD, CA 92010

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HYSTEM
HYSTEM
Registered 2009
GLYCOSIL
GLYCOSIL
Registered 2009
HEPRASIL
HEPRASIL
Registered 2009
GELIN-S
GELIN-S
Registered 2009
EXTRALINK
EXTRALINK
Registered 2009

Trademark Classifications

ADVANCED BIOMATRIX, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (5 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does ADVANCED BIOMATRIX, INC. have?

ADVANCED BIOMATRIX, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.

What trademark classes does ADVANCED BIOMATRIX, INC. file in?

ADVANCED BIOMATRIX, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 1 (Chemicals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are ADVANCED BIOMATRIX, INC.'s most well-known trademarks?

ADVANCED BIOMATRIX, INC.'s registered trademark portfolio includes well-known marks such as HYSTEM, GELIN-S, GLYCOSIL, HEPRASIL, and EXTRALINK. These are among 5 currently registered trademarks in the portfolio.

What is ADVANCED BIOMATRIX, INC.'s trademark registration success rate?

ADVANCED BIOMATRIX, INC. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.